These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 28862024)

  • 21. Role of Dynamic Contrast-Enhanced Perfusion Magnetic Resonance Imaging in Grading of Pediatric Brain Tumors on 3T.
    Gupta PK; Saini J; Sahoo P; Patir R; Ahlawat S; Beniwal M; Thennarasu K; Santosh V; Gupta RK
    Pediatr Neurosurg; 2017; 52(5):298-305. PubMed ID: 28848203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paradoxical perfusion metrics of high-grade gliomas with an oligodendroglioma component: quantitative analysis of dynamic susceptibility contrast perfusion MR imaging.
    Sunwoo L; Choi SH; Yoo RE; Kang KM; Yun TJ; Kim TM; Lee SH; Park CK; Kim JH; Park SW; Sohn CH; Won JK; Park SH; Kim IH
    Neuroradiology; 2015 Nov; 57(11):1111-20. PubMed ID: 26232204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-grade and anaplastic oligodendrogliomas: differences in tumour microvascular permeability evaluated with dynamic contrast-enhanced magnetic resonance imaging.
    Jia Z; Geng D; Liu Y; Chen X; Zhang J
    J Clin Neurosci; 2013 Aug; 20(8):1110-3. PubMed ID: 23673143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histogram analysis of dynamic contrast-enhanced magnetic resonance imaging for differentiating malignant from benign orbital lymphproliferative disorders.
    Xu XQ; Qian W; Hu H; Su GY; Liu H; Shi HB; Wu FY
    Acta Radiol; 2019 Feb; 60(2):239-246. PubMed ID: 29804475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perfusion parameters of intravoxel incoherent motion based on tumor edge region of interest in cervical cancer: evaluation of differentiation and correlation with dynamic contrast-enhanced MRI.
    Wang H; Zhu L; Li G; Zuo M; Ma X; Wang J
    Acta Radiol; 2020 Aug; 61(8):1087-1095. PubMed ID: 31825761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiation of Benign from Malignant Adnexal Masses by Dynamic Contrast-Enhanced MRI (DCE-MRI): Quantitative and Semi-quantitative analysis at 3-Tesla MRI.
    Gity M; Parviz S; Saligheh Rad H; Fathi Kazerooni A; Shirali E; Shakiba M; Baikpour M
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):1073-1079. PubMed ID: 31030476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain Gliomas: Multicenter Standardized Assessment of Dynamic Contrast-enhanced and Dynamic Susceptibility Contrast MR Images.
    Anzalone N; Castellano A; Cadioli M; Conte GM; Cuccarini V; Bizzi A; Grimaldi M; Costa A; Grillea G; Vitali P; Aquino D; Terreni MR; Torri V; Erickson BJ; Caulo M
    Radiology; 2018 Jun; 287(3):933-943. PubMed ID: 29361245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic Significance of DCE-MRI-Related Quantitative Parameters for Nasal Cavity and Sinus Tumors.
    Zhang H; Li LY; Yu LY; Liu NB; Yang D; Zhang SJ; Xu JH
    Altern Ther Health Med; 2024 Jul; 30(7):258-262. PubMed ID: 37971454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DSC and DCE Histogram Analyses of Glioma Biomarkers, Including IDH, MGMT, and TERT, on Differentiation and Survival.
    Zhang HW; Lyu GW; He WJ; Lei Y; Lin F; Wang MZ; Zhang H; Liang LH; Feng YN; Yang JH
    Acad Radiol; 2020 Dec; 27(12):e263-e271. PubMed ID: 31983532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnostic Value of Combining Permeability with T1 Perfusion Parameters in Quantitative Dynamic Contrast-enhanced Magnetic Resonance Imaging for Glioma Grading].
    Sun SJ; Qian HF; Li FQ; Li ZY; Wu X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2015 Dec; 37(6):674-80. PubMed ID: 26725390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of T1 mapping and fixed T1 method for dynamic contrast-enhanced MRI perfusion in brain gliomas.
    Conte GM; Altabella L; Castellano A; Cuccarini V; Bizzi A; Grimaldi M; Costa A; Caulo M; Falini A; Anzalone N
    Eur Radiol; 2019 Jul; 29(7):3467-3479. PubMed ID: 30972545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic Contrast-Enhanced Perfusion MRI and Diffusion-Weighted Imaging in Grading of Gliomas.
    Arevalo-Perez J; Peck KK; Young RJ; Holodny AI; Karimi S; Lyo JK
    J Neuroimaging; 2015; 25(5):792-8. PubMed ID: 25867683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating the Relationship Between Dynamic Contrast-Enhanced MRI (DCE-MRI) Parameters and Pathological Characteristics in Breast Cancer.
    Kang SR; Kim HW; Kim HS
    J Magn Reson Imaging; 2020 Nov; 52(5):1360-1373. PubMed ID: 32524658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective comparative diagnostic accuracy evaluation of dynamic contrast-enhanced (DCE) vs. dynamic susceptibility contrast (DSC) MR perfusion in differentiating tumor recurrence from radiation necrosis in treated high-grade gliomas.
    Zakhari N; Taccone MS; Torres CH; Chakraborty S; Sinclair J; Woulfe J; Jansen GH; Cron GO; Thornhill RE; McInnes MDF; Nguyen TB
    J Magn Reson Imaging; 2019 Aug; 50(2):573-582. PubMed ID: 30614146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discrimination between glioma grades II and III in suspected low-grade gliomas using dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging: a histogram analysis approach.
    Falk A; Fahlström M; Rostrup E; Berntsson S; Zetterling M; Morell A; Larsson HB; Smits A; Larsson EM
    Neuroradiology; 2014 Dec; 56(12):1031-8. PubMed ID: 25204450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined diffusion-weighted imaging and dynamic contrast-enhanced MRI for differentiating radiologically indeterminate malignant from benign orbital masses.
    Xu XQ; Qian W; Ma G; Hu H; Su GY; Liu H; Shi HB; Wu FY
    Clin Radiol; 2017 Oct; 72(10):903.e9-903.e15. PubMed ID: 28501096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving the Reliability of Pharmacokinetic Parameters at Dynamic Contrast-enhanced MRI in Astrocytomas: A Deep Learning Approach.
    Choi KS; You SH; Han Y; Ye JC; Jeong B; Choi SH
    Radiology; 2020 Oct; 297(1):178-188. PubMed ID: 32749203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perfusion-sensitive parameters of intravoxel incoherent motion MRI in rectal cancer: evaluation of reproducibility and correlation with dynamic contrast-enhanced MRI.
    Yang X; Xiao X; Lu B; Chen Y; Wen Z; Yu S
    Acta Radiol; 2019 May; 60(5):569-577. PubMed ID: 30114928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer.
    Kim Y; Kim SH; Song BJ; Kang BJ; Yim KI; Lee A; Nam Y
    Korean J Radiol; 2018; 19(4):682-691. PubMed ID: 29962874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative analysis of permeability for glioma grading using dynamic contrast-enhanced magnetic resonance imaging.
    Zhao M; Guo LL; Huang N; Wu Q; Zhou L; Zhao H; Zhang J; Fu K
    Oncol Lett; 2017 Nov; 14(5):5418-5426. PubMed ID: 29113174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.